review·Nature Reviews Disease Primers·Apr 14, 2016Closed access

Hepatocellular carcinoma

JMJosep M. LlovetCorresponding authorJZJessica Zucman‐RossiEPEli PikarskyBSBruno SangroMSM. Schwartz

Icahn School of Medicine at Mount Sinai · Institució Catalana de Recerca i Estudis Avançats · +13 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

2,647
total citations
FWCI
97.94
Percentile
100%
References
266
Citations per year

Authors

7
  • JM
    Josep M. LlovetCorresponding

    Icahn School of Medicine at Mount Sinai, Institució Catalana de Recerca i Estudis Avançats, Hospital Clínic de Barcelona

  • JZ
    Jessica Zucman‐Rossi

    Sorbonne Paris Cité, Université Paris Cité, Inserm, Délégation Paris 7, Délégation Paris 5, Université Sorbonne Paris Nord, Génomique Fonctionnelle des Tumeurs Solides

  • EP
    Eli Pikarsky
  • BS
    Bruno Sangro

    Clinica Universidad de Navarra, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

  • MS
    M. Schwartz

    Icahn School of Medicine at Mount Sinai

Topics & keywords

Topics
  • Primary topicHepatocellular Carcinoma Treatment and Prognosis100%
  • Hepatitis B Virus Studies100%
  • Liver Disease Diagnosis and Treatment100%
Keywords
  • Medicine
  • Hepatocellular carcinoma
  • Sorafenib
  • Oncology
  • Cancer
  • Internal medicine
  • Liver cancer
  • Ramucirumab
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.